177 related articles for article (PubMed ID: 20339907)
1. Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.
Yao H; Veine DM; Zeng ZZ; Fay KS; Staszewski ED; Livant DL
Clin Exp Metastasis; 2010 Mar; 27(3):173-84. PubMed ID: 20339907
[TBL] [Abstract][Full Text] [Related]
2. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.
Yao H; Veine DM; Fay KS; Staszewski ED; Zeng ZZ; Livant DL
Breast Cancer Res Treat; 2011 Jan; 125(2):363-75. PubMed ID: 20300829
[TBL] [Abstract][Full Text] [Related]
3. A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.
Veine DM; Yao H; Stafford DR; Fay KS; Livant DL
Clin Exp Metastasis; 2014 Apr; 31(4):379-93. PubMed ID: 24464034
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Yao H; Veine DM; Livant DL
Breast Cancer Res Treat; 2016 Jun; 157(3):489-501. PubMed ID: 27255534
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.
van Golen KL; Bao L; Brewer GJ; Pienta KJ; Kamradt JM; Livant DL; Merajver SD
Neoplasia; 2002; 4(5):373-9. PubMed ID: 12192595
[TBL] [Abstract][Full Text] [Related]
6. Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma.
Livant DL; Brabec RK; Pienta KJ; Allen DL; Kurachi K; Markwart S; Upadhyaya A
Cancer Res; 2000 Jan; 60(2):309-20. PubMed ID: 10667582
[TBL] [Abstract][Full Text] [Related]
7. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
8. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
Jia Y; Zeng ZZ; Markwart SM; Rockwood KF; Ignatoski KM; Ethier SP; Livant DL
Cancer Res; 2004 Dec; 64(23):8674-81. PubMed ID: 15574776
[TBL] [Abstract][Full Text] [Related]
9. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
10. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
11. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.
Doñate F; Parry GC; Shaked Y; Hensley H; Guan X; Beck I; Tel-Tsur Z; Plunkett ML; Manuia M; Shaw DE; Kerbel RS; Mazar AP
Clin Cancer Res; 2008 Apr; 14(7):2137-44. PubMed ID: 18381955
[TBL] [Abstract][Full Text] [Related]
13. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.
Stachurska A; Elbanowski J; Kowalczyńska HM
Cell Biol Int; 2012 Oct; 36(10):883-92. PubMed ID: 22686483
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.
Schirner M; Herzberg F; Schmidt R; Streit M; Schöning M; Hummel M; Kaufmann C; Thiel E; Kreuser ED
Clin Exp Metastasis; 1998 Jul; 16(5):427-35. PubMed ID: 10091938
[TBL] [Abstract][Full Text] [Related]
15. alpha(5)beta(1) Integrin Ligand PHSRN Induces Invasion and alpha(5) mRNA in Endothelial Cells to Stimulate Angiogenesis.
Zeng ZZ; Yao H; Staszewski ED; Rockwood KF; Markwart SM; Fay KS; Spalding AC; Livant DL
Transl Oncol; 2009 Mar; 2(1):8-20. PubMed ID: 19252747
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
17. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
[TBL] [Abstract][Full Text] [Related]
18. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
19. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
20. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]